儿科焦点的辅助治疗:系统性审查
Siru Wang1, Hu Sun2, Zhaoxuan Wang1
1School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, Shandong Province, China.
European journal of clinical pharmacology
|February 13, 2025
概括
这一网络元分析发现,拉莫特林和 levetiracetam 是有效和安全的辅助治疗焦点的儿童和青少年. 由于临床试验有限,需要进行进一步的研究来证实这些发现.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 在儿童群体中治疗需要有效和安全的辅助抗发作药物.
- 合理的药物选择对于优化儿童和青少年治疗结果至关重要.
研究的目的:
- 进行网络元分析,评估各种抗发作药物的疗效和安全性.
- 为合理使用儿科焦点的辅助治疗提供基于证据的指导.
主要方法:
- 在PubMed,Embase,Cochrane图书馆和Web of Science系统搜索随机临床试验,截至2023年12月10日.
- 包括19项随机对照试验,涉及2959名儿童患者,接受9种不同的抗发作药物治疗.
- 使用Cochrane协作工具 (RoB2) 和 Stata 15中执行的网络元分析进行偏差风险评估.
主要成果:
- 拉莫特里金, levetiracetam,lacosamide,oxcarbazepine,perampanel和zonisamide在50%的响应率方面表现出比安慰剂更高的疗效.
- 拉莫特里金和 levetiracetam 显示了最高的疗效概率.
- 埃斯利卡巴泽酸和 levetiracetam 实现了比安慰剂更频繁的发作自由.
- 托皮拉和牛碳胺与更高的副作用发生率有关.
结论:
- 根据疗效和安全性概况,建议使用拉莫特里金和 levetiracetam作为儿童和青少年焦点的首选辅助治疗方法.
- 这些发现突出了这些药物在儿童管理方面的潜力.
- 需要进一步的研究来验证这些结果,因为现有的随机临床试验数量有限.
相关概念视频
01:14Antiepileptic Drugs: Glutamate Antagonists
271
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
271
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
210
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
210
01:13Seizures: Classification
297
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
297
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
310
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
310
01:20Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
01:24Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177